Trials / Withdrawn
WithdrawnNCT02392546
Elobixibat Colonic Motor Function Study
A Single Center, Placebo-controlled Trial to Evaluate the Effects of Elobixibat in Colonic Motor Functions in Patients With Chronic Idiopathic Constipation
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized trial of 36 otherwise healthy patients with chronic idiopathic constipation. The purpose of the study is to compare the effects of daily single-dose oral elobixibat and placebo for 7 days on colonic motor effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | elobixibat | |
| DRUG | placebo |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2015-03-19
- Last updated
- 2015-06-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02392546. Inclusion in this directory is not an endorsement.